Marcel Mück
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marcel Mück has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Brian Clarke
Division of Computational Genomics and Systems Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
2 shared publications - Eva Holtkamp
Institute of Computational Biology, Helmholtz Center Munich, Neuherberg, Germany
2 shared publications - Felix Brechtmann
School of Computation, Information and Technology, Technical University of Munich, Garching, Germany
2 shared publications Felix Munzlinger
AI Health Innovation Cluster, German Cancer Research Center (DKFZ), Heidelberg, Germany
2 shared publications- Hakime Öztürk
Dept. of Computer Engineering Bogaziçi University Istanbul Turkey
2 shared publications - Julien Gagneur
TUM School of Computation, Information and Technology, Technical University of Munich, Garching, Germany
2 shared publications
Latest Publications
- Open Access
- 25 September 2024
- Published by Springer Nature in Nature Genetics
- Vol. 56 (10) , 2271-2280
Integration of variant annotations using deep set networks boosts rare variant association testing
Rare genetic variants can have strong effects on phenotypes, yet accounting for rare variants in genetic analyses is statistically challenging due to the limited number of allele carriers and the burden of multiple testing. While rich variant annotations promise to enable well-powered rare variant association tests, methods integrating variant annotations in a data-driven manner are lacking. Here we propose deep rare variant association testing (DeepRVAT), a model based on set neural networks that learns a trait-agnostic gene impairment score from rare variant annotations and phenotypes, enabling both gene discovery and trait prediction. On 34 quantitative and 63 binary traits, using whole-exome-sequencing data from UK Biobank, we find that DeepRVAT yields substantial gains in gene discoveries and improved detection of individuals at high genetic risk. Finally, we demonstrate how DeepRVAT enables calibrated and computationally efficient rare variant tests at biobank scale, aiding the discovery of genetic risk factors for human disease traits.
- 25 September 2024
- Published by Springer Nature in Nature Genetics
- Vol. 56 (10) , 2271-2280
Open AccessIntegration of variant annotations using deep set networks boosts rare variant association testing
Rare genetic variants can have strong effects on phenotypes, yet accounting for rare variants in genetic analyses is statistically challenging due to the limited number of allele carriers and the burden of multiple testing. While rich variant annotations promise to enable well-powered rare variant association tests, methods integrating variant annotations in a data-driven manner are lacking. Here we propose deep rare variant association testing (DeepRVAT), a model based on set neural networks that learns a trait-agnostic gene impairment score from rare variant annotations and phenotypes, enabling both gene discovery and trait prediction. On 34 quantitative and 63 binary traits, using whole-exome-sequencing data from UK Biobank, we find that DeepRVAT yields substantial gains in gene discoveries and improved detection of individuals at high genetic risk. Finally, we demonstrate how DeepRVAT enables calibrated and computationally efficient rare variant tests at biobank scale, aiding the discovery of genetic risk factors for human disease traits.
- Open Access
Integration of variant annotations using deep set networks boosts rare variant association genetics
Rare genetic variants can strongly predispose to disease, yet accounting for rare variants in genetic analyses is statistically challenging. While rich variant annotations hold the promise to enable well-powered rare variant association tests, methods integrating variant annotations in a data-driven manner are lacking. Here, we propose DeepRVAT, a model based on set neural networks that learns burden scores from rare variants, annotations, and phenotypes. In contrast to existing methods, DeepRVAT yields a single, trait-agnostic, nonlinear gene impairment score, enabling both risk prediction and gene discovery in a unified framework. On 34 quantitative and 26 binary traits, using whole-exome-sequencing data from UK Biobank, we find that DeepRVAT offers substantial increases in gene discoveries and improved replication rates in held-out data. Moreover, we demonstrate that the integrative DeepRVAT gene impairment score greatly improves detection of individuals at high genetic risk. Finally, we show that pre-trained DeepRVAT scores generalize across traits, opening up the possibility to conduct highly computationally efficient rare variant tests.
Open AccessIntegration of variant annotations using deep set networks boosts rare variant association genetics
Rare genetic variants can strongly predispose to disease, yet accounting for rare variants in genetic analyses is statistically challenging. While rich variant annotations hold the promise to enable well-powered rare variant association tests, methods integrating variant annotations in a data-driven manner are lacking. Here, we propose DeepRVAT, a model based on set neural networks that learns burden scores from rare variants, annotations, and phenotypes. In contrast to existing methods, DeepRVAT yields a single, trait-agnostic, nonlinear gene impairment score, enabling both risk prediction and gene discovery in a unified framework. On 34 quantitative and 26 binary traits, using whole-exome-sequencing data from UK Biobank, we find that DeepRVAT offers substantial increases in gene discoveries and improved replication rates in held-out data. Moreover, we demonstrate that the integrative DeepRVAT gene impairment score greatly improves detection of individuals at high genetic risk. Finally, we show that pre-trained DeepRVAT scores generalize across traits, opening up the possibility to conduct highly computationally efficient rare variant tests.